Capdevila, J, Paez, D, Villacampa, MM, Garcia-Alvarez, A, Aparicio, J, Pampols, M, Riesco-Martinez, MD, Polo, E, Ruiz-Casado, A, Castañon, C, Soriano, S, Hernando, J, Navalpotro, B, Armario, D, Villacampa, G, Horvath, E, Virgili, AC, Asiain, L, Giménez, A, Guillot, M. Atezolizumab plus tiragolumab in combination with chemoradiotherapy in localized squamous cell carcinoma of the anal canal: TIRANUS (GEMCAD-2103) trial.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(2_SUPPL)DOI:10.1200/JCO.2026.44.2_suppl.11. PMID:. IF:41.900(Q1/1D).

Hayes, M, Nakajima, TE, Seecof, O, Majem, M, Chenji, S, Ashki, N, Ceccarelli, M, Van Cutsem, E. A phase 2 randomized, double-blind, placebo-controlled study to evaluate LY3537021 for the treatment of chemotherapy-induced nausea and vomiting in patients with malignant disease.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(2_SUPPL)DOI:10.1200/JCO.2026.44.2_suppl.TPS855. PMID:. IF:41.900(Q1/1D).

Martín, AJM, Castet, F, Vera, R, Alvarez, R, Garcia-Alfonso, P, Alsar, JS, Palao, P, Diaz, IA, Vidal-Tocino, R, Adeva, J, Modrego, A, Maseda, AC, Martínez-Galán, J, Serda, PC, Rodriguez-Alonso, RM, Aranda, E, La Casta, A, de Castro, EM, Montes, AFF, Macarulla, T. Isocitrate dehydrogenase 1 mutations in biliary tract cancer patients in Spanish RETUD registry. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(2_SUPPL)DOI:10.1200/JCO.2026.44.2_suppl.500. PMID:. IF:41.900(Q1/1D).

Martín, AJM, Castet, F, Vera, R, Alvarez, R, Pertusa, C, Garcia-Alfonso, P, Rodríguez, RJ, Vidal-Tocino, R, Diaz, IA, Caro, NL, Adeva, J, Paladines, WGP, Maseda, AC, Rodriguez-Alonso, RM, Aranda, E, Serda, PC, de Castro, EM, La Casta, A, Laquente, B, Macarulla, T. ERBB2/HER2 status in biliary tract cancer patients in the Spanish RETUD registry.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(2_SUPPL)DOI:10.1200/JCO.2026.44.2_suppl.498. PMID:. IF:41.900(Q1/1D).

Alonso-Gordoa, T, Anguera, G, Domínguez-Esteban, M, Reig, O, Martínez-Barros, H, Molina-Cerrillo, J, Cruz, P, Maroto, P. Expert consensus on patterns of progression in kidney cancer after adjuvant immunotherapy and subsequent treatment strategies. CANCER TREATMENT REVIEWS. 2025; 136DOI:10.1016/j.ctrv.2025.102925. PMID:40186886. IF:10.500(Q1/1D).

Favaro, MTP, Alamo, P, Roher, N, Chillon, M, Lascorz, J, Márquez, M, Corchero, JL, Mendoza, R, Martínez-Torró, C, Ferrer-Miralles, N, Ferreira, LCS, Mangues, R, Vázquez, E, Parladé, E, Villaverde, A. Zinc-Assisted Microscale Granules Made of the SARS-CoV-2 Spike Protein Trigger Neutralizing, Antivirus Antibody Responses. ACS Materials Letters. 2024; 6(3)DOI:10.1021/acsmaterialslett.3c01643. PMID:. IF:8.700(Q1/2D).

Vergouwen, MDI, Ramos-Pachon, A, Terecoasa, EO, Willett, N, Cuadrado-Godia, E, Gaberel, T, Gizewski, ER, Helbok, R, Ho, LA, Hugelshofer, M, Korja, M, Meling, TR, Psychogios, MN, Rinkel, GJE, Taschner, CA, Vajkoczy, P, Etminan, N. European Stroke Organisation (ESO), European Association of Neurosurgical Societies (EANS) and European Society for Minimally Invasive Neurological Therapy (ESMINT) guideline on aneurysmal subarachnoid haemorrhage. European Stroke Journal. 2026; 11(5)DOI:10.1093/esj/aakag043. PMID:42095754. IF:4.500(Q1/2D).

Lambea-Gil, A, Camps-Renom, P, Martí-Fàbregas, J, Guasch-Jiménez, M, Ezcurra-Díaz, G, Fernández-Vidal, JM, Prats-Sanchez, L, Martínez-Domeño, A, de la Ossa, NP, Ramos-Pachón, A. Early care limitation after ICH in a population-based study: what drives clinicians' decisions?. European Stroke Journal. 2026; 11(4)DOI:10.1093/esj/aakag028. PMID:41947561. IF:4.500(Q1/2D).

van Kleef, ESB, Bouman, K, Molenaar, JPF, Küsters, B, Groothuis, JT, Olivé, M, Malfatti, E, Kamsteeg, EJ, Van Engelen, BGM, Ottenheijm, CAC, Doorduin, J, Voermans, NC. Nemaline Myopathy Type 6 Caused by Variants in the KBTBD13 Gene. Neurology-Genetics. 2024; 10(6)DOI:10.1212/NXG.0000000000200214. PMID:39651462. IF:3.700(Q1/3D).

Dominguez-González, C, Romero, MAB, Eraso, CC, de las Heras, J, Muñoz, EF, Garcia-Campos, O, González, M, Grau, JM, Hernández-Voth, A, Morales, RJ, Hernández, JCL, Martos, ML, López-Padilla, D, Muelas, N, Nascimento, A, Olivé, M, Paradas, C, Fernández, JP, Pascual, SI, Pitarch, I, Sancho, J, Diaz-Manera, J. Recommendations for the diagnostic, treatment, and follow-up of late-onset Pompe disease. NEUROLOGIA. 2026; 41(2)DOI:10.1016/j.nrl.2025.501933. PMID:41453611. IF:3.100(Q2/4D).

Torchia, E, Lucchini, M, Verdu-Diaz, J, Bortolani, S, Ravera, B, Carlomagno, V, Cicia, A, Bernardo, D, Monforte, M, Rehmann, R, Kley, RA, Sabatelli, M, Díaz-Manera, J, Ricci, E, Mirabella, M, Tasca, G. Muscle Imaging in Inclusion Body Myositis: Refinement of MRI Criteria and Insights Into Upper Body Involvement. Journal of Cachexia Sarcopenia and Muscle. 2026; 17(1)DOI:10.1002/jcsm.70173. PMID:41549703. IF:9.100(Q1/1D).

Doneddu, PE, Collet-Vidiella, R, Gallo, C, Cocito, D, Manganelli, F, Falzone, Y, Dalla Bella, E, Benedetti, L, Mazzeo, A, Peci, E, Spina, E, Strano, C, Germano, F, Gentile, L, Liberatore, G, Cutellè, C, Bianchi, E, Querol, L, Nobile-Orazio, E. Effect of Rituximab on Neurofilament Levels in CIDP: Results From the CIDPRIT Randomized Trial. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2026; 31(1)DOI:10.1111/jns.70107. PMID:41649095. IF:3.200(Q2/4D).

De Pedro, S, Presa, M, Gamez, J, Fernández, FJG, Querol, L. Cost Analysis of Immunoglobulin Maintenance Treatment of Patients with Chronic Inflammatory Demyelinating Polyneuropathy in Spain. Pharmacoeconomics-Open. 2026; 10(2)DOI:10.1007/s41669-025-00633-8. PMID:41528376. IF:(Q/D).

Costas-Carrera, A, Verdolini, N, Garcia-Rizo, C, Mezquida, G, Janssen, J, Valli, I, Corripio, I, Sanchez-Torres, AM, Bioque, M, Lobo, A, Gonzalez-Pinto, A, Rapado-Castro, M, Vieta, E, de la Serna, H, Mane, A, Roldan, A, Crossley, N, Penades, R, Cuesta, MJ, Parellada, M, Bernardo, M. Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis. PSYCHOLOGICAL MEDICINE. 2024; DOI:10.1017/S0033291723003185. PMID:38014924. IF:5.500(Q1/1D).

Argyelan M, Deng ZD, Ousdal OT, Oltedal L, Angulo B, Baradits M, Spitzberg AJ, Kessler U, Sartorius A, Dols A, Narr KL, Espinoza R, van Waarde JA, Tendolkar I, van Eijndhoven P, van Wingen GA, Takamiya A, Kishimoto T, Jorgensen MB, Jorgensen A, Paulson OB, Yrondi A, Péran P, Soriano-Mas C, Cardoner N, Cano M, van Diermen L, Schrijvers D, Belge JB, Emsell L, Bouckaert F, Vandenbulcke M, Kiebs M, Hurlemann R, Mulders PC, Redlich R, Dannlowski U, Kavakbasi E, Kritzer MD, Ellard KK, Camprodon JA, Petrides G, Malhotra AK, Abbott CC. Correction: Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression.. MOLECULAR PSYCHIATRY. 2024; 29(2)DOI:10.1038/s41380-023-02358-8. PMID:38052984. IF:(Q/D).

Saura, J, Feliu, A, Enriquez-Mestre, M, Fu, M, Ballbe, M, Castellano, Y, Pla, M, Rosa, N, Radeva, P, Maestre-Gonzalez, E, Cabezas, C, Colom, J, Suelves, JM, Mondon, S, Barrio, P, Andreu, M, Raich, A, Bernabeu, J, Vilaplana, J, Tutusaus, XR, Guydish, J, Fernandez, E, Martinez, C. Patterns of Use and Withdrawal Syndrome in Dual Cannabis andTobacco Users (DuCATA_GAM-CAT):Protocol for a MixedMethods Study. Jmir Research Protocols. 2024; 13DOI:10.2196/58335. PMID:39298750. IF:(Q/D).

Pegueroles, J, Montal, V, Bejanin, A, Vilaplana, E, Aranha, M, Santos-Santos, MA, Alcolea, D, Carrio, I, Camacho, V, Blesa, R, Lleo, A, Fortea, J. AMYQ: An index to standardize quantitative amyloid load across PET tracers. ALZHEIMERS & DEMENTIA. 2021; 17(9)DOI:10.1002/alz.12317. PMID:33797846. IF:16.655(Q1/1D).

Abras, A, Ballart, C, Fernández-Arévalo, A, Llovet, T, Gállego, M, Muñoz, C. Assessment of Alinity s Chagas® as a Primary Diagnostic Test for Chronic Chagas Disease in a Non-Endemic Area of Europe (Barcelona, Spain). Life-Basel. 2024; 14(10)DOI:10.3390/life14101278. PMID:39459578. IF:3.400(Q1/3D).

Salamanca-Rivera, E, Palacios-Baena, ZR, Cañada, JE, Moure, Z, Pérez-Vázquez, M, Calvo-Montes, J, Martínez-Martínez, L, Cantón, R, Carrascoso, GR, Pitart, C, Navarro, F, Bou, G, Mulet, X, González-López, JJ, Sivianes, F, Delgado-Valverde, M, Pascual, A, Oteo-Iglesias, J, Rodríguez-Baño, J. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain. INFECTION. 2024; DOI:10.1007/s15010-024-02267-0. PMID:38703288. IF:3.600(Q2/3D).

Agarwal, N, Castellano, D, Alonso-Gordoa, T, Arija, JAA, Colomba, E, Gravis, G, Mourey, L, Oudard, S, Fléchon, A, González, M, Rey, PM, Schweizer, MT, Gallardo, E, Johnston, E, Balar, A, Haddad, N, Appiah, AK, Nacerddine, K, Piulats, JM. A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer: Results from CYCLONE 1. CLINICAL CANCER RESEARCH. 2024; 30(11)DOI:10.1158/1078-0432.CCR-23-3436. PMID:38512117. IF:10.200(Q1/1D).

Falgàs A., Garcia-León A., Núñez Y., Serna N., Sánchez-Garcia L., Unzueta U., Voltà-Durán E., Aragó M., Álamo P., Alba-Castellón L., Sierra J., Gallardo A., Villaverde A., Vázquez E., Mangues R., Casanova I.. A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4(+) lymphoma cells without toxicity in immunocompromised and immunocompetent mice. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2022; 150DOI:10.1016/j.biopha.2022.112940. PMID:35421785. IF:7.500(Q1/1D).

Volta-Durán, E, Alba-Castellon, L, Arena, LA, Sánchez, JM, Casanova, I, Mangues, R, Villaverde, A, Vázquez, E, Unzueta, U. KDEL-mediated modulation of intracellular trafficking in cell-targeted protein drugs. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 2026; 222DOI:10.1016/j.ejpb.2026.115020. PMID:41690333. IF:4.300(Q1/2D).

Favaro, MTP, Volta-Duran, E, Sanchez, JM, Escribano-Ferrer, E, Huaca, V, Miranda-Tovar, E, Unzueta, U, Parlade, E, Vazquez, E, Mangues, R, Villaverde, A, Casanova, I. Biomimetic Protein Materials for Adjuvant-Free Dermal Penetration. ACS Materials Letters. 2026; 8(4)DOI:10.1021/acsmaterialslett.5c01250. PMID:41982275. IF:8.700(Q1/2D).

Vives, S, Quintela, D, Morgades, M, Cano-Ferri, I, Serrano, A, Acuña-Cruz, E, Cervera, M, Díaz-Beyá, M, Vidriales, B, Raposo-Puglia, JA, Arnan, M, Garrido, A, Balerdi, A, Cabello, AI, Herrera-Puente, P, Serrano, J, Coll, R, Tormo, M, López-Marín, J, García-Avila, S, Casado, MS, Padilla, I, Rodríguez-Macías, G, Calbacho, M, Puchol, A, Hernández, A, Torres, M, Costilla, L, Colorado, MM, Martínez-Cuadrón, D, Esteve, J, Montesinos, P. Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups. Cancers. 2024; 16(23)DOI:10.3390/cancers16234028. PMID:39682214. IF:4.400(Q2/3D).

Camps-Renom, P, Guasch-Jiménez, M, Martinez-Domeño, A, Prats-Sánchez, L, Ramos-Pachón, A, Alvarez-Cienfuegos, J, Silva, Y, Fortea-Cabo, G, Morales-Caba, L, Rodríguez-Campello, A, Giralt-Steinhauer, E, Flores, A, Ustrell, X, López-Hernández, N, Corona-García, DJ, Freijo-Guerrero, MM, Luna, A, Tejada-Meza, H, Marta-Moreno, J, Moniche, F, Pardo-Galiana, B, Castellanos, M, Albert-Lacal, L, Sanz-Monllor, A, Aguilera-Simón, A, Marín, R, Ezcurra-Díaz, G, Lambea-Gil, A, Marti-Fàbregas, J. A Randomized Trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE). CEREBROVASCULAR DISEASES. 2025; 54(4)DOI:10.1159/000540606. PMID:39208776. IF:1.500(Q3/8D).

Font, MA, García-Sánchez, SM, Mengual, JJ, Avellaneda, C, Boned, S, Doncel-Moriano, A, Urra, X, Camps-Renom, P, de la Ossa, NP, Terceño, M, Yugueros, B, Ustrell, X, Purroy, F, Rodríguez-Campello, A, Molina, C, Krupinski, J, Aguirre, GF, Baraldes, M, Jiménez-Fàbrega, X, Salvat-Plana, M, Elosua, R, Abilleira, S, Cardona, P, Gómez-Choco, M. Early neurological deterioration before endovascular treatment in patients with mild stroke. MINORCAT-END-EVT study. Journal of Stroke & Cerebrovascular Diseases. 2026; 35(3)DOI:10.1016/j.jstrokecerebrovasdis.2026.108584. PMID:41679406. IF:1.800(Q3/7D).

Montalvo, C, Garcia-Tornel, A, Olive-Gadea, M, Rodrigo-Gisbert, M, Requena, M, Rizzo, F, Rodriguez-Luna, D, Rodriguez-Villatoro, N, Pagola, J, Simonetti, R, de la Ossa, NP, Camps-Renom, P, Canovas, D, Flores, A, Rodriguez-Campello, A, Silva, Y, Urra, X, Purroy, F, Bustamante, A, Salvat-Plana, M, Cardona, P, Molina, C, Rubiera, M, Ribo, M. Socioeconomic Deprivation in Ischemic Stroke Treated With Endovascular Thrombectomy: Not All Recoveries Are Equal. STROKE. 2026; 57(2)DOI:10.1161/STROKEAHA.125.052865. PMID:41208686. IF:8.900(Q1/1D).

Tiedt, S, Bustamante, A, Cameron, A, Camps-Renom, P, Grosse, GM, Ospel, J, Volbers, B, Audebert, HJ, Aulin, J, Cheng, BS, Cordonnier, C, Coutinho, JM, Fonseca, AC, Hill, MD, Jensen, M, Jern, C, Kamtchum-Tatuene, J, Katan, M, Kelly, PJ, Kopczak, A, Lemmens, R, Lindgren, AG, Loan, JJM, Nolte, CH, Puy, L, Saba, L, Salman, RA, Sandset, EC, Selim, MH, Seners, P, Sprigg, N, Tsai, HH, Doyle, KM, Montaner, J, Schreuder, FHBM, Sposato, L, Samarasekera, N, Mccabe, JJ. Biomarkers for advancing diagnosis and prognosis in stroke. LANCET NEUROLOGY. 2026; 25(4)DOI:10.1016/S1474-4422(25)00480-6. PMID:41864237. IF:45.500(Q1/1D).

Dietz, S, Avula, A, Kumar, A, Petersen, N, Guasch-Jimenez, M, Slowik, A, Wrona, P, Dhar, R. White Matter Hyperintensities Are Associated with Worse Outcomes but Not Greater Cerebral Edema or Hemorrhagic Transformation After Large Vessel Occlusion Stroke. STROKE. 2026; 57(SUPPL_1)DOI:10.1161/str.57.suppl_1.DP035. PMID:. IF:8.900(Q1/1D).

de Sousa, DA, Katsanos, AH, Li, LX, Martinez-Majander, N, McCabe, J, Palaiodimou, L, Pachon, AR, Romoli, M, Schellinger, PD, Zietz, A, Poli, S, Roaldsen, M, Shoamanesh, A, Sykora, M, Tsivgoulis, G. ESO annual stroke evidence update 2025. European Stroke Journal. 2026; 11(2)DOI:10.1093/esj/aakag009. PMID:41706824. IF:4.500(Q1/2D).

Cortés-Vicente, E, Guerrero, A, Díaz, C, Martínez, E, Toja-Camba, FJ, Abad, MR, Serra, JM, Trillo, JL, Machín, CM, Gil, A. Assessing the Value Contribution of Vyvgart® (Efgartigimod Alfa) in the Treatment of Generalized Myasthenia Gravis with Acetylcholine Receptor Antibody in Spain Through Multi-criteria Decision Analysis (Jan, 10.1007/s12325-026-03490-x, 2026). ADVANCES IN THERAPY. 2026; 43(5)DOI:10.1007/s12325-026-03532-4. PMID:41817916. IF:4.000(Q1/3D).

Campos-Lucas, FJ, Cortés-Vicente, E, Guerrero-Sola, A, Alvarez-Velasco, R, Pardo-Gómez, R, Gómez-Salgado, J, Antón-Rodríguez, C, Caballero-Martínez, F. Patient Perceptions of Needs and Expectations Regarding the Current Management of Myasthenia Gravis: A Biopsychosocial Study. Neurology and Therapy. 2026; 15(3)DOI:10.1007/s40120-026-00892-5. PMID:41721962. IF:4.800(Q1/2D).

Vesperinas, A, Rocaspana-Codana, J, Reyes-Leiva, D, Caballero-Avila, M, Carbayo, A, Collet-Vidiella, R, Llansó, L, Gallardo, E, Turon-Sans, J, Rojas-García, R, Cortés-Vicente, E. Digital Monitoring of Patients with Generalized Myasthenia Gravis: A Prospective Pilot Study. Neurology and Therapy. 2026; 15(3)DOI:10.1007/s40120-026-00932-0. PMID:41957339. IF:4.800(Q1/2D).

Santos García D, Pagonabarraga Mora J, Escamilla Sevilla F, García Ruiz PJ, Infante Ceberio J, Kulisevsky Bojarski J, Linazasoro Cristóbal G, Luquín Piudo MR, Martínez Castrillo JC, Jesús Maestre S, Vela Desojo L, Campos Lucas FJ, Caballero Martínez F, Mir P. Dopamine agonist therapy in Parkinson's disease: Spanish expert consensus on its use in different clinical situations.. Neurologia. 2025; 40(2)DOI:10.1016/j.nrleng.2023.04.008. PMID:37419211. IF:(Q/D).

Negrini-Ferrari, SE, Martínez-Martel, I, Pol, O. Molecular Hydrogen Reverses Nociplastic Pain and Depressive-like Behaviors via Region- and Sex-Dependent Central Mechanisms. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2026; 27(7)DOI:10.3390/ijms27073051. PMID:41977237. IF:4.900(Q1/3D).

Goya-Maldonado, R, Erwin-Grabner, T, Zeng, LL, Ching, CRK, Aleman, A, Amod, AR, Basgoze, Z, Benedetti, F, Besteher, B, Brosch, K, Bülow, R, Colle, R, Connolly, CG, Corruble, E, Couvy-Duchesne, B, Cullen, K, Dannlowski, U, Davey, CG, Dols, A, Ernsting, J, Evans, JW, Fisch, L, Fuentes-Claramonte, P, Gonul, AS, Gotlib, IH, Grabe, HJ, Groenewold, NA, Grotegerd, D, Hahn, T, Hamilton, JP, Han, LKM, Harrison, B, Ho, TC, Jahanshad, N, Jamieson, AJ, Karuk, A, Kircher, T, Klimes-Dougan, B, Koopowitz, SM, Lancaster, T, Leenings, R, Li, M, Linden, DEJ, Macmaster, FP, Mehler, DMA, Meinert, S, Melloni, E, Mueller, BA, Mwangi, B, Nenadic, I, Ojha, A, Okamoto, Y, Oudega, ML, Penninx, BWJH, Poletti, S, Pomarol-Clotet, E, Portella, MJ, Radua, J, Rodriguez-Cano, E, Sacchet, MD, Salvador, R, Schrantee, A, Sim, K, Soares, JC, Solanes, A, Stein, DJ, Stein, F, Stolicyn, A, Thomopoulos, SI, Toenders, YJ, Uyar-Demir, A, Vieta, E, Vives-Gilabert, Y, Völzke, H, Walter, M, Whalley, HC, Whittle, S, Winter, N, Wittfeld, K, Wright, MJ, Wu, MJ, Yang, TT, Zarate, C, Veltman, DJ, Schmaal, L, Thompson, PM. Classification of major depressive disorder using vertex-wise brain sulcal depth, curvature, and thickness with a deep and a shallow learning model. MOLECULAR PSYCHIATRY. 2026; 31(3)DOI:10.1038/s41380-025-03273-w. PMID:41044403. IF:10.100(Q1/1D).

González-Blanch, C, López-Carrilero, R, Bobes-Bascarán, T, Catalán, A, Aymerich, C, Rodriguez-Jimenez, R, Gutiérrez-Zotes, A, Díaz-Mandado, O, González-Pinto, A, Cano-Escalera, G, Zubia, M, Guinart, D, del-Castillo-Serrano, M, Vilella, E, García-Alvarez, L, Ochoa, S, Correa-Ghisays, P, Balanzá-Martínez, V, Sánchez-Ortí, JV, Pousa, E, Miret, S, Falip, C, Reguera-Pozuelo, P, Fernández-Martínez, R, García-Cabeza, I, Campos-Rodriguez, C, Crosas, JM, Cobo, J, Pardina-Torner, H, Perona-Garcelán, S, Muñoz-Caracuel, M, Yorca-Ruiz, A, de la Foz, VOG, Ayesa-Arriola, R. Validation of the virtual reality functional capacity assessment tool (VRFCAT) in a Spanish sample of individuals with psychosis and healthy controls. EUROPEAN PSYCHIATRY. 2025; 68(1)DOI:10.1192/j.eurpsy.2025.10134. PMID:41249148. IF:6.700(Q1/1D).

Schmidt, C, Otero, D, Pascual, JC, Romero, S, Puntí, J, Lara, A, Sintes, A, Méndez, I, Nicolaou, S, Soler, J, Vega, D. Differential Psychological and Social Impact of the COVID-19 Pandemic on Spanish Youth With and Without Non-Suicidal Self-Injury: A Longitudinal Analysis. ACTAS ESPANOLAS DE PSIQUIATRIA. 2026; 54(2)DOI:10.62641/aep.v54i2.2043. PMID:42023465. IF:1.600(Q3/7D).

Bonnín, CM, Montejo, L, Torrent, C, Sánchez-Moreno, J, de Diego-Adeliño, J, Solé, B, Roca, X, Hidalgo-Mazzei, D, Borràs, R, Clougher, D, Valentí, M, Martínez-Arán, Cardoner, N, Vieta, E. Psychosocial functional recovery in patients with bipolar disorder in remission: Which symptoms hold them back?. JOURNAL OF AFFECTIVE DISORDERS. 2026; 403DOI:10.1016/j.jad.2026.121442. PMID:41698620. IF:4.900(Q1/2D).

Pinzon-Espinosa, J, Erausquin, JT, Millender, EF, Rincon, T, Talavero, GC, Franco-Paredes, C, Cardoner, N, Hall, CDX, Wong, FY, Wang, LY, Alvarez, C, Gabster, A. Mental health and quality of life of migrants in transit through the Darien gap: A cross-sectional assessment in Panama. Journal Of Migration And Health. 2026; 13DOI:10.1016/j.jmh.2026.100405. PMID:41994504. IF:(Q/D).